The FDA Just Lost Its Drug Chief, Biologics Chief, and Chief of Staff in 72 Hours

Five CDER heads in one year. Fewer than half of senior FDA leaders from six months ago remain. Capital Alpha called it "the most damaging period in FDA history." Relay outpaced Novartis in rare disease. AbbVie locked Rinvoq generics out until 2037.

Видео The FDA Just Lost Its Drug Chief, Biologics Chief, and Chief of Staff in 72 Hours канала BioMed Nexus